We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$615M
AUM Growth
-$265M
Cap. Flow
-$210M
Cap. Flow %
-34.24%
Top 10 Hldgs %
73.3%
Holding
97
New
9
Increased
13
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$3.8M
2
LHX icon
L3Harris
LHX
+$2.71M
3
MCK icon
McKesson
MCK
+$2.6M
4
UNH icon
UnitedHealth
UNH
+$2.21M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.95M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$43.4M
2
UPS icon
United Parcel Service
UPS
+$25.2M
3
KO icon
Coca-Cola
KO
+$19M
4
DIS icon
Walt Disney
DIS
+$8.27M
5
PG icon
Procter & Gamble
PG
+$7.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 56.11%
2 Energy 10.64%
3 Healthcare 10.54%
4 Industrials 7.86%
5 Technology 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$127B
$3.65M 0.59%
81,738
-881,455
-92% -$43.4M
SYY icon
27
Sysco
SYY
$39.7B
$3.27M 0.53%
95,700
+22,000
+30% +$808K
NUE icon
28
Nucor
NUE
$56.4B
$3.08M 0.5%
71,003
-28,671
-29% -$1.47M
LOW icon
29
Lowe's Companies
LOW
$116B
$3.04M 0.49%
74,287
-53,605
-42% -$2.5M
TGT icon
30
Target
TGT
$62.1B
$2.98M 0.48%
43,281
-2,253
-5% -$133K
WMB icon
31
Williams Companies
WMB
$90.5B
$2.87M 0.47%
88,400
-43,500
-33% -$2.02M
CMCSA icon
32
Comcast
CMCSA
$79.1B
$2.74M 0.45%
131,400
-198,572
-60% -$5.1M
ORCL icon
33
Oracle
ORCL
$331B
$2.66M 0.43%
86,600
-58,500
-40% -$2.41M
RTN
34
DELISTED
Raytheon Company
RTN
$2.59M 0.42%
+39,151
New +$3.8M
HD icon
35
Home Depot
HD
$332B
$2.39M 0.39%
30,800
-5,202
-14% -$410K
INTU icon
36
Intuit
INTU
$81.1B
$2.39M 0.39%
39,100
+400
+1% +$30.9K
BP icon
37
BP
BP
$113B
$2.21M 0.36%
64,799
-11,382
-15% -$469K
XLNX
38
DELISTED
Xilinx Inc
XLNX
$2.19M 0.36%
55,300
+34,500
+166% +$1.66M
LLY icon
39
Eli Lilly
LLY
$1.07T
$2.02M 0.33%
41,200
+7,300
+22% +$436K
NSC icon
40
Norfolk Southern
NSC
$78.8B
$2M 0.33%
27,584
-17,746
-39% -$1.74M
ZBH icon
41
Zimmer Biomet
ZBH
$17.7B
$1.97M 0.32%
27,089
-6,592
-20% -$643K
CVS icon
42
CVS Health
CVS
$137B
$1.87M 0.3%
32,675
-3,000
-8% -$227K
BA icon
43
Boeing
BA
$165B
$1.85M 0.3%
18,062
-5,998
-25% -$783K
UNH icon
44
UnitedHealth
UNH
$382B
$1.84M 0.3%
+28,100
New +$2.21M
LHX icon
45
L3Harris
LHX
$55.9B
$1.79M 0.29%
+36,345
New +$2.71M
SBUX icon
46
Starbucks
SBUX
$118B
$1.74M 0.28%
52,980
-14,312
-21% -$520K
MCK icon
47
McKesson
MCK
$98.5B
$1.67M 0.27%
+14,600
New +$2.6M
ETN icon
48
Eaton
ETN
$157B
$1.64M 0.27%
24,900
-40,506
-62% -$3.01M
UNP icon
49
Union Pacific
UNP
$183B
$1.64M 0.27%
10,600
-25,200
-70% -$2.44M
DD
50
DELISTED
Du Pont De Nemours E I
DD
$1.61M 0.26%
32,327
+7,540
+30% +$485K

Similar funds

Cullinan Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Cullinan Associates held 97 positions worth $615M, down 30% from $879M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Cullinan Associates withdrew a net $210M in Q2 2014, closing 17 positions and reducing 57 holdings. Its most notable exit was VF Corp, an estimated $7.28M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Cullinan Associates opened a new position in Raytheon Company worth $2.59M.

  • Cullinan Associates's largest Q2 2014 buy was Raytheon Company: 39,151 shares worth $2.59M.
  • Cullinan Associates added most to Xilinx Inc in Q2 2014, an estimated $1.66M increase.
  • Cullinan Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $43.4M.
  • Cullinan Associates fully exited VF Corp in Q2 2014, selling an estimated $7.28M.
  • Cullinan Associates's ten largest holdings make up 73% of its $615M portfolio in Q2 2014.
  • Cullinan Associates opened 9 new positions and closed 17 in Q2 2014.
  • Cullinan Associates's portfolio value fell 30% quarter-over-quarter to $615M.

Based on Cullinan Associates's 13F filing for Q2 2014, filed 15 Aug 2014.